IP Library Granted Patent US 7,399,872
Granted Patent B2
US 7,399,872 · App. 10/469,928 · Granted Jul 15, 2008

Conversion of CBD to Δ

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,872
App. No.
10/469,928
Granted
Jul 15, 2008
Kind
B2
Abstract

Methods of converting cannabidiol to Δ 8 -tetrahydrocannabinol or Δ 9 -tetrahydrocannabinol are described. The described methods produce higher yields and higher purity compared to prior art methods.

Claims (15)

1. A method of converting cannabidiol (CBD) to Δ 9 -tetrahydrocannabinol (Δ 9 -THC) comprising:

providing a reaction mixture comprising CBD in dry methylene chloride;

adding BF 3 Et 2 O to the reaction mixture;

stirring the ice cold reaction mixture under a nitrogen atmosphere;

adding NaHCO 3 to the reaction mixture;

allowing the mixture to separate into an aqueous phase and an organic phase;

removing the organic phase;

washing the organic layer with water; and

eluting Δ 9 -THC from the organic phase, purity of the eluted Δ 9 -THC being greater than 97%.

2. The method according to claim 1 including stirring the reaction mixture for approximately 1 hour.

3. The method according to claim 1 including drying the organic phase over MgSO 4 and evaporating the organic phase following washing.

4. The method according to claim 1 including eluting the organic phase on an HPLC column.

5. The method according to claim 4 wherein the Δ 9 -THC is eluted with ether in petroleum ether following washing the column with petroleum ether.

6. The method according to claim 5 wherein the ether in petroleum ether is 2 parts ether in 98 parts petroleum ether.

7. The method according to claim 1 including eluting the organic phase on an RP-HPLC column.

Assignments (3)
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2012
From: CANADIAN MEDICAL HEMP, INC.
To: FULL SPECTRUM LABORATORIES LIMITED
Reel/Frame 027860/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2012
From: WEBSTER, G.R. BARRIE, DR.; SARNA, LEONARD P.; MECHOULAM, RAPHAEL, DR.
To: CANADIAN MEDICAL HEMP, INC.
Reel/Frame 027719/0007 →
Continuity (2)
Provisional Application 6027362800 · Mar 7, 2001
Related Publication 20040143126A1 · Jul 22, 2004